Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

UPDATE 3-Ghana kicks off coronavirus vaccination campaign with COVAX shots

Published 02/03/2021, 22:34
Updated 02/03/2021, 22:36
© Reuters

© Reuters

* President says Ghana to inoculate 20 million people by
year-end
* COVAX vaccines scheme accelerates deliveries
* Nigeria, Angola, Congo receive COVAX vaccines on Tuesday

(Updates with vaccine delivery to Congo and Gambia)
By Christian Akorlie
ACCRA, March 2 (Reuters) - Ghana launched its coronavirus
vaccination drive on Tuesday with doses from the global COVAX
vaccine-sharing programme, which delivered shipments to other
African countries as its vaccine rollout to developing nations
accelerates.
The start of vaccinations in Ghana, and in neighbouring
Ivory Coast on Monday, along with the expected delivery of
millions of vaccines from the COVAX programme this week, will
enable more poor countries to start inoculating mostly frontline
workers and the most vulnerable, months after wealthier
countries began.
COVAX is the programme backed by the World Health
Organization and GAVI vaccine alliance to provide vaccines for
poor and middle-income countries. It said on
Tuesday it aims to deliver 237 million doses of AstraZeneca (NASDAQ:AZN)'s
shot to 142 countries by the end of May. On Tuesday, COVAX delivered 3.92 million doses of the
vaccine to Nigeria, 1.7 million doses to Democratic Republic of
Congo, 624,000 to Angola and 36,000 to Gambia. Senegal expects
324,000 doses from the scheme to arrive on Wednesday.
"This is a historic and momentous occasion for The Gambia,"
Health Minister Ahmadou Lamin Samateh said in a statement.
In Ghana, people lined up outside the regional hospital in
the capital, Accra, for a first phase of vaccinations which is
prioritising frontline health workers and others at high risk.
"I feel so good about taking the vaccine. It will protect me
from contracting the virus from patients," said Bernice
Anaglatey, 42, who works in the COVID-19 intensive care unit at
Accra's Ridge Hospital as she queued for her shot.
The West African country aims to vaccinate 20 million
people, or over 66% of its population, by the end of 2021,
according to President Nana Akufo-Addo.
Drones from U.S.-based startup Zipline delivered some of the
vaccines to health facilities, making Ghana the first in the
world to use the technology on a national scale to deliver
COVID-19 shots, the company said.
Only a handful of other African countries have started
inoculations, with doses bought bilaterally or received as
donations.
Vaccine shipments through the COVAX scheme are expected to
accelerate this week with the delivery of 11 million AstraZeneca
and Pfizer-BioNTech PFE.N 22UAy.DE doses.
Health authorities are also stepping up efforts to fight
conspiracy theories around the vaccines. President Akufo-Addo
and his wife were inoculated on Monday in an effort to boost
public confidence in the vaccines. nL5N2KY0W2]
"The stories I heard about the vaccine have put fear in me,"
said Isaac Armah, a 28-year-old trader in Accra. "I'll wait for
about two months to see the effects of the vaccine on the early
recipients, then I'll make up my mind."
Coronavirus infections in Ghana have surpassed 84,000 and
more than 600 people have died, according to health ministry
data.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
FACTBOX-Latest on the worldwide spread of the coronavirus
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.